CoChat

Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways

Open access
Marquardt, Jens U., Raggi, Chiara, Andersen, Jesper B., Seo, Daekwan, Avital, Itzhak, Geller, David, Lee, Yun-Han, Kitade, Mitsuteru, Holczbauer, Agnes, Gillen, Matthew C., Conner, Elizabeth A., Factor, Valentina M., Thorgeirsson, Snorri S. · 2011 · Hepatology
Cited by 84

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Epigenetic mechanisms play critical roles in stem cell biology by maintaining pluripotency of stem cells and promoting differentiation of more mature derivatives. If similar mechanisms are relevant for the cancer stem cell (CSC) model, then epigenetic modulation might enrich the CSC population, thereby facilitating CSC isolation and rigorous evaluation. To test this hypothesis, primary human cancer cells and liver cancer cell lines were treated with zebularine (ZEB), a potent DNA methyltransferase-1 inhibitor, and putative CSCs were isolated using the side population (SP) approach. The CSC properties of ZEB-treated and untreated subpopulations were tested using standard in vitro and in vivo assays. Whole transcriptome profiling of isolated CSCs was performed to generate CSC signatures. Clinical relevance of the CSC signatures was evaluated in diverse primary human cancers. Epigenetic modulation increased frequency of cells with CSC properties in the SP fraction isolated from human cancer cells as judged by self-renewal, superior tumor-initiating capacity in serial transplantations, and direct cell tracking experiments. Integrative transcriptome analysis revealed common traits enriched for stemness-associated genes, although each individual CSC gene expression signature exhibited activation of different oncogenic pathways (e.g., EGFR , SRC, and MYC). The common CSC signature was associated with malignant progression, which is enriched in poorly differentiated tumors, and was highly predictive of prognosis in liver and other cancers. Conclusion: Epigenetic modulation may provide a tool for prospective isolation and in-depth analysis of CSC. The liver CSC gene signatures are defined by a pernicious interaction of unique oncogene-specific and common stemness traits. These data should facilitate the identifications of therapeutic tools targeting both unique and common features of CSCs. (HEPATOLOGY 2011;)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.24454

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 84

Metadata

Authors
Marquardt, J. U., Raggi, C., Andersen, J. B., Seo, D., Avital, I., Geller, D., Lee, Y.-H., Kitade, M., Holczbauer, A., Gillen, M. C., Conner, E. A., Factor, V. M., & Thorgeirsson, S. S.
Venue
Hepatology
Published
2011-09-02
Volume
54
Issue
3
Pages
1031-1042
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2075563306
Cited by
84
References
5
FWCI
4.69
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways. https://app.cochat.ai/papers/10.1002/hep.24454
The paper
Marquardt, J. U., Raggi, C., Andersen, J. B., Seo, D., Avital, I., Geller, D., Lee, Y.-H., Kitade, M., Holczbauer, A., Gillen, M. C., Conner, E. A., Factor, V. M., & Thorgeirsson, S. S. (2011). Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways. Hepatology. https://doi.org/10.1002/hep.24454

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.